glp-1 risk factors The expanding role of receptor agonists: a narrative review of current evidence and future directions Obesity and cardiovascular disease consensus

10.1161/HYPERTENSIONAHA.113.02767 86

Once the ligand binds to the receptor, SMO inhibition is lifted, leading to the activation of downstream transcription factors, namely glioma-associated oncogene homologs (Gli1, Gli2, and Gli3), in the nucleus (307)

Metabolism slows, muscle mass declines, hormonal shifts alter how the body stores fat, and the caloric deficit required to produce meaningful weight loss becomes more difficult to sustain through diet and exercise alone

During implantation, the immune system must strike a precise balance supportive enough to allow tissue remodelling, yet tolerant enough to accept an embryo